Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
16.17
-0.52 (-3.12%)
Dec 3, 2024, 1:48 PM EST - Market open
Myriad Genetics Employees
Myriad Genetics had 2,700 employees as of December 31, 2023. The number of employees increased by 100 or 3.85% compared to the previous year.
Employees
2,700
Change (1Y)
100
Growth (1Y)
3.85%
Revenue / Employee
$305,037
Profits / Employee
-$42,963
Market Cap
1.48B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
U.S. Physical Therapy | 6,720 |
Evolent Health | 4,700 |
Arcus Biosciences | 577 |
BioCryst Pharmaceuticals | 536 |
Harrow | 315 |
Kiniksa Pharmaceuticals International, | 297 |
Arcutis Biotherapeutics | 296 |
Nurix Therapeutics | 284 |
MYGN News
- 12 days ago - Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina's Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2 - GlobeNewsWire
- 15 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 16 days ago - Myriad Genetics, Inc. (MYGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 18 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Shareholders to Inquire about Securities Investigation - Accesswire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Shareholders to Connect - Accesswire
- 20 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Myriad Genetics, Inc. (MYGN) And Encourages Investors to Connect - Accesswire
- 21 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Stockholders to Inquire about Securities Investigation - Accesswire
- 22 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Myriad Genetics, Inc. (MYGN) and Encourages Investors to Learn More About the Investigation - Accesswire